Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Tandem Transplant for High-Risk Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Daratumumab Carfilzomib Lenalidomide and Dexamethasone with tandem transplant in high-risk newly diagnosed myeloma
Blood 2024 Feb 23;[EPub Ahead of Print], C Touzeau, A Perrot, C Hulin, S Manier, M Macro, ML Chretien, L Karlin, M Escoffre, C Jacquet, M Tiab, X Leleu, H Avet-Loiseau, A Jobert, L Planche, J Corre, P MoreauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.